AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of Surgical Joint Denervation in Painful Digital Osteoarthritis

RecruitingNAAges 18 Years - anyAllAssistance Publique - Hôpitaux de Paris
💬

In plain words

What the trial is, and whether it could suit you

Digital osteoarthritis is the second localization of symptomatic osteoarthritis, after the knee. Its cardinal symptoms are particularly intense pain and functional impairment in the case of the erosive form. There is currently no etiological treatment for osteoarthritis. Symptomatic treatments have a modest efficacy, which justifies the search for new treatments. The surgical options are arthrodesis or prosthesis, invasive techniques potentially sources of complications, and finally proposed infrequently given the prevalence of digital osteoarthritis. DECAD is a prospective phase II trial aimed at evaluating the efficacy of surgical joint denervation in painful digital osteoarthritis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * Patients with symptomatic digital osteoarthritis according to the criteria of the American College of Rheumatology * 1 painful PIP joint (Analog digital scale ≥ 4/10) for more than 3 months * having failed the usual medical treatment for a minimum of 3 months (level 1 analgesics, NSAIDs, infiltrations) * Signature of informed consent * patient affiliated to a social security scheme * knowing how to read French (for the questionnaires) Exclusion Criteria: * digital osteoarthritis secondary to other known causes (eg gout, reactive arthritis, RA, psoriatic arthritis, spondyloarthropathies, septic arthritis) * anesthetic contraindications to surgery or to performing an MRI * Existence of a pain syndrome in the upper limbs, which would interfere with the assessment of AD. * Fibromyalgia * Use of oral, intramuscular or intra-articular or intravenous corticosteroids, immunosuppressants (methotrexate, sulfasalazine, leflunomide, biomedicines), hyaluronic acid infiltration in the finger joints in the previous month * Introduction of a new treatment for osteoarthritis of the hand in the previous month, including physiotherapy and fitting of a new finger orthosis. * History of denervation of the proximal interphalangeal joint (PIP) * Patient under legal protection (guardianship or curatorship) and patient deprived of liberty * Patient under AME * Participation in another interventional research involving the human person or period of exclusion at the end of a previous research involving the human person.
💊

What it tests

  • Surgical Denervation
📍

Where

1 site
Rheumatology department Saint-Antoine Hospital
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy